Literature DB >> 17389290

An intervention to improve secondary prevention of coronary heart disease.

Thomas C Bailey1, Laura A Noirot, Amy Blickensderfer, Erin Rachmiel, Robyn Schaiff, Anthony Kessels, Alan Braverman, Anne Goldberg, Brian Waterman, W Claiborne Dunagan.   

Abstract

BACKGROUND: Translating guidelines into clinical practice has proved to be quite difficult, even when the guidelines are well accepted and noncontroversial. Both computerized reminders and academic detailing have been effective in changing physician prescribing behavior. In this study, we sought to use these methods, mediated by clinical pharmacists, to improve adherence to the secondary prevention guidelines in hospitalized patients with myocardial infarction.
METHODS: A randomized, prospective study was performed in which computerized alerts identifying hospitalized patients with elevated troponin I levels were routed to clinical pharmacists. The pharmacists then conducted academic detailing for physicians caring for patients with acute myocardial infarction who were randomized to the intervention group. Patients in the control group received standard care. The main outcome measure was the proportion of patients discharged on a regimen of aspirin, beta-blockers, angiotensin-converting enzyme inhibitors, and statins.
RESULTS: The intervention had a significant impact on the proportion of patients discharged on a regimen of angiotensin-converting enzyme inhibitors (328/365 [89.9%] vs 409/488 [83.8%], intervention vs control, respectively, P = .02), and statins (344/365 [94.2%] vs 436/488 [89.3%], P = .02). There was no statistical impact on beta-blocker (350/365 [95.9%] vs 448/488 [91.8%], P = .10) or aspirin use (352/365 [96.4%] vs 471/488 [96.5%], P = .87). When all 4 classes were considered together, 305 (83.6%) of 365 patients vs 343 (70.3%) of 488 patients were discharged on a regimen of all secondary prevention medications to which they did not have a contraindication (P<.001).
CONCLUSION: A computerized alert with pharmacist-mediated academic detailing is an effective means to increase adherence to secondary prevention guidelines for coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17389290     DOI: 10.1001/archinte.167.6.586

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  11 in total

Review 1.  Cardiovascular health disparities: a systematic review of health care interventions.

Authors:  Andrew M Davis; Lisa M Vinci; Tochi M Okwuosa; Ayana R Chase; Elbert S Huang
Journal:  Med Care Res Rev       Date:  2007-10       Impact factor: 3.929

2.  Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France.

Authors:  J Bezin; A Pariente; R Lassalle; C Dureau-Pournin; A Abouelfath; P Robinson; N Moore; C Droz-Perroteau; A Fourrier-Reglat
Journal:  Eur J Clin Pharmacol       Date:  2013-11-24       Impact factor: 2.953

3.  Use of evidence-based pharmacotherapy for secondary prevention of coronary heart disease: a Chinese medicine hospital versus a general hospital.

Authors:  Hui-min Xu; Hong-wen Cai; Hai-bin Dai; Xiao-feng Yan; Quan Zhou; Geng Xu; Zhao-quan Huang; Wei Mao
Journal:  Chin J Integr Med       Date:  2014-01-23       Impact factor: 1.978

Review 4.  The effectiveness of integrated health information technologies across the phases of medication management: a systematic review of randomized controlled trials.

Authors:  K Ann McKibbon; Cynthia Lokker; Steven M Handler; Lisa R Dolovich; Anne M Holbrook; Daria O'Reilly; Robyn Tamblyn; Brian J Hemens; Runki Basu; Sue Troyan; Pavel S Roshanov
Journal:  J Am Med Inform Assoc       Date:  2011-08-18       Impact factor: 4.497

5.  Adherence to treatment guidelines in two primary care populations with gout.

Authors:  Geoffrey C Wall; Carrie F Koenigsfeld; Karly A Hegge; Michelle M Bottenberg
Journal:  Rheumatol Int       Date:  2009-07-10       Impact factor: 2.631

6.  Hospital-Based Quality Improvement Interventions for Patients With Acute Coronary Syndrome: A Systematic Review.

Authors:  Ehete Bahiru; Anubha Agarwal; Mark A Berendsen; Abigail S Baldridge; Tecla Temu; Amy Rogers; Carey Farquhar; Frederick Bukachi; Mark D Huffman
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2019-09-06

7.  Assessing cardiometabolic parameter monitoring in inpatients taking a second-generation antipsychotic: The CAMI-SGA study - a cross-sectional study.

Authors:  Jennifer Fontaine; Evelyn Chin; Jean-François Provencher; Anthony Rainone; Dana Wazzan; Carmella Roy; Soham Rej; Marie Lordkipanidze; Vincent Dagenais-Beaulé
Journal:  BMJ Open       Date:  2022-04-12       Impact factor: 2.692

8.  A pharmacist-led follow-up program for patients with established coronary heart disease in North Norway - a randomized controlled trial.

Authors:  Beate H Garcia; Trude Giverhaug; June U Høgli; Frode Skjold; Lars Småbrekke
Journal:  Pharm Pract (Granada)       Date:  2015-06-15

9.  A pharmacist-led follow-up program for patients with coronary heart disease in North Norway--a qualitative study exploring patient experiences.

Authors:  Beate Hennie Garcia; Sissel Lisa Storli; Lars Småbrekke
Journal:  BMC Res Notes       Date:  2014-03-29

10.  Impact of a pharmacist-delivered discharge and follow-up intervention for patients with acute coronary syndromes in Qatar: a study protocol for a randomised controlled trial.

Authors:  Amani Zidan; Ahmed Awaisu; Nadir Kheir; Ziyad Mahfoud; Rasha Kaddoura; Sumaya AlYafei; Maguy Saffouh El Hajj
Journal:  BMJ Open       Date:  2016-11-18       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.